$115.87
1.731.52%
Últ. Act.: Aug 21, 11:15 AM
Abbott Laboratories
ABTNYSE
Abbott Laboratories Earnings & Forecasts
Abbott Laboratories (ABT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Abbott Laboratories Guidance
Abbott Laboratories (ABT) emitió su última guía sobre julio 16, 2026 para Q3 2026. La compañía estimó unas ganancias por acción en el rango de $1.38 - $1.46, en comparación con una estimación de consenso de EPS de $1.42.
En comparación con la previsión anterior, Abbott Laboratories reducido redujo su previsión de BPA desde un rango anterior de $5.45 - $5.6.
Abbott Laboratories ha emitido 27 actualizaciones de orientación entre el octubre 19, 2022 y el julio 16, 2026. During this period, the company raised its outlook 6 times and lowered it 10 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.28 | $1.14 | $1.50 | $1.30 |
| Actual | $1.31 | $1.15 | $1.50 | $1.30 |
| Surprise | +2.34% | +0.88% | 0.00% | 0.00% |
| Revenue | ||||
| Estimate | $12.51B | $11.01B | $11.80B | $11.40B |
| Actual | $12.59B | $11.16B | $11.46B | $11.37B |
| Surprise | +0.66% | +1.43% | -2.87% | -0.30% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.42 | $1.64 | $1.30 | $1.49 |
| Revenue | ||||
| Consensus | $12.97B | $13.52B | — | — |